This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
—Recent editorials in British journals indicate a lack of information concerning the purpose and the mode of administration of the patents obtained by us covering scarlet fever preparations. Had the author of the articles read our communication on this subject published in The Journal, Sept. 26, 1925, p. 996, he would know that there is no cause for alarm.The results of the research to which he refers were published in the latter part of 1923 and the beginning of 1924. At that time, it was suggested to us that the taking out of a patent on the materials described would safeguard their quality. We were not convinced of the necessity for such a step and refused to consider it. In a short time the distribution of the scarlet fever preparations was begun by commercial manufacturers. Some of these products were undesirable, because of faulty methods of
Dick GF, Dick GH. THE PATENTS IN SCARLET FEVER TOXIN AND ANTITOXIN. JAMA. 1927;88(17):1341–1342. doi:10.1001/jama.1927.02680430043026
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: